MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No. Ebers GC Mult Scler. 2014 Mar; 20(3):282-3. PMID: 24589686. Abstract CommentRecommendBookmarkWatch